1. Epizyme Reports the US FDA Acceptance of NDA for Tazverik (tazemetostat) to Treat Follicular Lymphoma Published: Feb 14, 2020 | Tags: Epizyme, Reports, US, FDA, Acceptance, NDA, Tazverik, tazemetostat, Follicular […]readmore
Tags : Dr. Reddy’s Laboratories
Biosimilars
Dr. Reddy’s Laboratories Launches Versavo (biosimilar, bevacizumab) for Multiple Cancer
Shots: Dr. Reddy’s has launched Versavo (bevacizumab), a biosimilar of Roche’s Avastin in 100mg and 400mg single use vials for the treatment of multiple cancers including m-colorectal cancer, NSCLC, recurrent […]readmore
Shots: Dr. Reddy’s to receive $70M upfront, $40.5M as milestones, an additional payment including existing contractual obligation and inventory with royalties on sales on a quarterly basis Upsher-Smith to get […]readmore